Cochrane Abstracts
The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"The Effects of Idarubicin Versus Other Anthracyclines for Induction Therapy of Patients With Newly Diagnosed Leukaemia." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/The_effects_of_idarubicin_versus_other_anthracyclines_for_induction_therapy_of_patients_with_newly_diagnosed_leukaemia.
The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/The_effects_of_idarubicin_versus_other_anthracyclines_for_induction_therapy_of_patients_with_newly_diagnosed_leukaemia. Accessed January 20, 2026.
The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/The_effects_of_idarubicin_versus_other_anthracyclines_for_induction_therapy_of_patients_with_newly_diagnosed_leukaemia
The Effects of Idarubicin Versus Other Anthracyclines for Induction Therapy of Patients With Newly Diagnosed Leukaemia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/The_effects_of_idarubicin_versus_other_anthracyclines_for_induction_therapy_of_patients_with_newly_diagnosed_leukaemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia
ID - 432908
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/The_effects_of_idarubicin_versus_other_anthracyclines_for_induction_therapy_of_patients_with_newly_diagnosed_leukaemia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
